My wife is 51 and has generally struggled with constipation for as long as I’ve known her (many decades). Several weeks ago, ...

Fintel reports that on December 11, 2024, Wells Fargo initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

The panelist discusses Vowst, an FDA-approved live microbiota therapeutic that works by introducing healthy donor-derived gut ...

The panelist discusses Rebyota, a treatment approved by the FDA for preventing recurrent Clostridioides difficile infections in adults who have completed antibiotic treatment for recurrent C difficile ...

Your digestive system does more than just process food—it’s home to trillions of tiny organisms, mostly bacteria, that play a ...

In the largest study of its kind in the UK, a research team from Queen’s University Belfast have discovered a new way to ...

Following the previously announced successful End of Phase 2 Meeting achieving agreement with FDA on non-clinical and clinical Phase 3-readiness, Acurx has now also received written positive feedback ...

which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical ...

The gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.1% during the third quarter, according to ...

Fintel reports that on December 6, 2024, Jefferies initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy ...